CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | Epperly Melissa B, Chief Financial Officer | Sale | −5,227 | $19.98 | $104K | 392,048 |
| 2023-02-14 | Gallagher Cam President | Sale | −8,501 | $19.96 | $170K | 491,270 |
| 2023-02-14 | Bunker Kevin D. Chief Scientific Officer | Sale | −6,500 | $19.98 | $130K | 865,157 |
| 2023-02-13 | Epperly Melissa B, Chief Financial Officer | Sale | −2,624 | $20.42 | $54K | 397,275 |
| 2023-02-13 | Gallagher Cam President | Sale | −3,332 | $20.42 | $68K | 499,771 |
| 2023-02-13 | Bunker Kevin D. Chief Scientific Officer | Sale | −3,807 | $20.42 | $78K | 871,657 |
| 2023-02-06 | Gallagher Cam President | Sale | −9,428 | $22.22 | $210K | 503,675 |
| 2023-02-06 | Gallagher Cam President | Sale | −572 | $23.04 | $13K | 503,103 |
| 2023-02-01 | Bunker Kevin D. Chief Scientific Officer | Grant or award | +91,354 | 875,464 | ||
| 2023-02-01 | Bunker Kevin D. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +132,646 | 132,646 | ||
| 2023-02-01 | Gallagher Cam President | Grant or award | +161,092 | 513,103 | ||
| 2023-02-01 | Gallagher Cam President | Grant or award · Stock Option (Right to Buy) | +233,908 | 233,908 | ||
| 2023-02-01 | Blackwell Kimberly Chief Executive Officer | Grant or award | +244,800 | 249,800 | ||
| 2023-02-01 | Blackwell Kimberly Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +355,200 | 355,200 | ||
| 2023-02-01 | Epperly Melissa B, Chief Financial Officer | Grant or award | +101,957 | 399,899 | ||
| 2023-02-01 | Epperly Melissa B, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +148,043 | 148,043 | ||
| 2023-02-01 | Paul Andrea General Counsel | Grant or award | +40,783 | 40,783 | ||
| 2023-02-01 | Paul Andrea General Counsel | Grant or award · Stock Option (Right to Buy) | +59,217 | 59,217 | ||
| 2023-02-01 | Brownstein Carrie Chief Medical Officer | Grant or award | +16,313 | 116,313 | ||
| 2023-02-01 | Brownstein Carrie Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +23,687 | 23,687 |
Page 6 of 8 · 160 trades